Specialty Laboratories Presents: Diagnosis and Management of Superficial Transitional Cell Carcinoma of the Bladder Learn about new markers for the diagnosis and management of transitional cell carcinoma of the bladder. Post Conference Material Evaluation Form Post Test Questions Bladder Tumor Marker CME

At the end of the program, participants will be able to describe: 1 . the common presentations of superficial bladder cancer 2. the role of urine cytology in the diagnosis and management of transitional cell carcinoma of the bladder 3. newer techniques for evaluating urinary sediment for cancer cells. Barry S. Stein, MD Krisnamurthi Family Professor and Chief of Urology Brown Medical School.

* Henry Mayo Newhall Memorial Hospital (HMNMH) is accredited by the Institute of Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. HMNMH takes responsibility for the content, quality, and scientific integrity of this CME activity. HMNMH designates this educational activity for a maximum of 1 AMA PRA Category 1 credit™. Physicians should claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.